RV-142(CAS 84611-22-3) is an intermediate(P-1) used for the synthesis of Erdosteine 

We are currently manufacturing and supplying RV-142(Erdosteine's Intermediate) for the manufacturers of Erdoteine API all over the world.

Erdostein is a drug that thins sputum and makes it easier to excrete. It is classified as a mucolytic agent among mucolytic agents and has an expectorant effect. Mucoactive drugs refer to all drugs that affect the nature and quantity of sputum and excretion, and are classified as follows according to the mechanism of action.

Mucolytics - Lowers the viscosity by dissolving sputum

Expectorants - Increases mucus secretion and causes coughing, causing sputum to drain from the lungs or bronchi

Mucoregulators - Reduces mucus secretion

Mucokinetics - Promotes the secretion of mucus, resulting in lower viscosity


Product Information

Chemical Name:

RV-142
N-Chloroacetyl-DL-homocysteine thiolactone

Synonyms:

2-Chloro-N-(tetrahydro-2-oxo-3-thienyl)acetamide;

CAS Number:

84611-22-3

Molecular Formula:

C₆H₈ClNO₂S

Appearance:

White to Off-White Solid

Melting Point:

120 - 122ºC

Molecular Weight:

193.65

Storage:

Room Temperature not exceeding 30°C

Solubility:

DMSO (Slightly), Methanol (Slightly)

Category:

Pharmaceutical API Intermediate FOR Erdosteine
(Classified as Chemical)

Production Information

Production Status

Commercial / Bulk

Capacity

50MT~80MT / YEAR

MOQ

250KG

Batch Size

250KG

Packaging

25KG/Fiber Drum

Erdosteine Market may outperform USD 160 million by 2025; according to another investigation report.

Extending inescapability of standard respiratory issues, for instance, hack, cold, and bronchitis will trigger the arrangements of erdosteine. It is commonly used in collecting prescriptions to control and improve the reactions that go with outrageous making of organic liquid owing to illnesses achieved by immune issues, smoking, hypersensitivities, for instance, residue and soil which will stimulate bit of the general business.

Growing smoking examples in making economies such Indonesia, India, and China inferable from climb in additional money, and liberal lifestyles will help erdosteine marker demand. Perpetual smoking affinities have been associated with overproduction of natural liquid associated with disorders, for instance, smokers hack and wearisome bronchitis. Taken in smokes crushes cilia that are huge for the sound improvement of natural liquid to the throat and it gathers in the bronchioles bundling thickening of organic liquid, and irritation in throat. Erdosteine is used in gathering prescriptions for rule of natural liquid creation inferable from its mucolytic and antibacterial properties which will develop market advancement.

Erdosteine market demand from sedate industry was regarded at over USD 45 million of each 2018. Growing occurrences of steady respiratory issues, for instance, asthma, unremitting obstructive pneumonic issues, and emphysema inferable from climb in air contaminants, for instance, nitrogen and sulfur oxides, consuming particles, nitrates, ground level ozone, and smelling salts will develop market advancement for erdosteine. These contaminants cause extension of the larynx and pharynx setting off the formation of organic liquid to fight sullying causing obstructs, and respiratory issues.

Erdosteine market demand from foundations may enroll gains at around 5.5% up to 2025. Climb in clinical and imaginative examples in therapeutic administrations industry turning around tranquilize steady transport systems and cutting down collecting cost will enliven bit of the pie. Addition in financing across top universities in U.S. additionally, Europe, for instance, Harvard Clinical School, John Hopkins School, Stanford Drug, and Yale Establishment of Medicine will develop market improvement. Distinctive clinical fundamentals in schools are in progress to qualify and assess the sufficiency of erdosteine in respiratory and cardiovascular diseases which will grow bit of the pie.

Industry individuals in erdosteine market involve Recipharm Muscular strength, Delta Finochem, Altitair Medications, Hanmi Medications, Taj Medications, and Hikma Medications. Associations are busy with extreme investigation to find substitute ways to deal with manufacture erdosteine by cysteine to cut down costs, improving the idea of things to fulfill regulatory guidelines, and expanding topographical proximity.

As API, around 140MT is used per a year. 80MT of 140MT is used in South Korea.

Quotation & Supply Inquiry to

danielthetiger8954@gmail.com